Poor sleep is directly correlated to an increased risk of a number of health conditions, from memory problems to chronic diseases. Obstructive sleep apnea (OSA) is a sleep breathing disorder that affects an estimated 54 million Americans* and is linked with cardiovascular disease, stroke, Type 2 diabetes, accidents, and reduced quality of life.
Despite the condition’s high prevalence and increasing public awareness, past research has shown that approximately 80% of individuals with OSA are undiagnosed** and that the current care options are often inconvenient and expensive.
In an effort to explore improving current approaches to sleep apnea management, Verily’s Sleep Apnea Study 2 is evaluating a new approach to sleep apnea management which is intended to provide patients with a more seamless experience from initial diagnosis to therapy enrollment, with the goal of improving the quality of their sleep. As a digital, fully at-home study, the Sleep Apnea Study 2 allows participants to join research in a way that blends sleep therapy into their daily life.
This study is part of Verily’s joint venture with global digital health and sleep apnea leader ResMed, announced in July, 2018, “to more efficiently identify, diagnose, treat, and manage individuals with sleep apnea and other breathing-related sleep disorders.”
Participants will sign up through Verily’s clinical research initiative and technology platform Project Baseline. Project Baseline enables participants to volunteer for research opportunities that fit their profile, interests, and lifestyle.
If eligible, participants will begin the study with a virtual physician appointment to assess symptoms and evaluate if a home sleep test is right for them. Participants who are diagnosed with sleep apnea and elect to start PAP therapy will use the Verily Sleep Apnea smartphone app. The Verily Sleep Apnea app is designed to help people adjust to PAP therapy, and to build and maintain healthy sleep behaviors and routines, thereby supporting not only the patients but their doctors and home medical equipment providers who have increasingly embraced digital health solutions as means to increase patient adherence and business efficiency.
Improving sleep can help people enhance their health and their quality of life.
The Sleep Apnea Study 2 has the potential to provide meaningful insights into how we approach obstructive sleep apnea diagnosis and care. The platform pairs a supportive, holistic approach with a streamlined care pathway leveraging Verily’s unique expertise, to improve sleep health and lives in ways that matter deeply.” said Shannon Sullivan, M.D., Principal Investigator.
To learn more about the study and its mission to improve the lives of patients with sleep apnea, visit our website . This study is currently seeking participants who have not yet been diagnosed with obstructive sleep apnea and who live in North Carolina or Texas.
* Lancet Respir Med. 2019 Aug; 7(8): 687–698., 9 July, 2019.
** “Hidden Health Crisis Costing America Billions,” Frost & Sullivan, 2016.
Updated Wednesday, July 15, 2020